DR. GREGORY KEITH TERPSTRA DO NPI 1952399792

NPI Details

DR. Gregory Keith Terpstra, DO is a family medicine in Potosi, MO with 33 years of experience. The provider is family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity. DR. Gregory Keith Terpstra, DO NPI is 1952399792. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF MICHIGAN MEDICAL SCHOOL
Graduation Year:1993

The provider's business location address is:

612 E HIGH ST STE 210
POTOSI, MO
ZIP 63664-426
Phone: (573) 438-3660
Fax: (573) 438-1140

The NPI 1952399792 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The CLIA number assigned to this NPI record is 26D0921211 - physician office with a certificate type of Certificate for Provider-Performed Microscopy Procedures (PPMP).

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Annual depression screening, 15 minutes (HCPCS:G0444)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Destruction of precancer skin growth, 2-14 growths (HCPCS:17003)
• Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) (HCPCS:87811)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Influenza vaccine, quadrivalent, 0.5 ml dosage (HCPCS:90688)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit (HCPCS:G0438)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 10/6/2005 and was last updated on 5/13/2008.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.